Abstract
In a patient with liver disease coming for an intracranial procedure, the clinician should keep in mind the pathophysiology of the liver disease while planning a strategy for controlling the intracranial pressure. Maintaining the cerebral perfusion pressure in a patient with a compromised cerebrovascular reserve is a challenge.
The prime issues in neuroanesthesia that an anesthesiologist is required to tackle are brain relaxation, hyperventilation, arterial blood pressure management, use of steroids, osmotherapy, diuretics, anticonvulsant use, patient positioning, intraoperative blood loss, and intravenous fluid management. The prime concerns in a patient with liver disease include coagulation problems, malnutrition, potential ascites, abnormal metabolism of drugs, pulmonary hypertension, high cardiac output and a low systemic vascular resistance state, bleeding from esophageal varices, potential for hepatorenal syndrome, and hepatic encephalopathy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut. 2008;57:268.
Schepke M, Heller J, Paschke S, et al. Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: evidence for a receptor-specific mechanism. Hepatology. 2001;34:884.
Palma DT, Fallon MB. The hepatopulmonary syndrome. J Hepatol. 2006;45:61.
Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome–a liver-induced lung vascular disorder. N Engl J Med. 2008;358:2378–87.
Rodriguez-Roisin R, Krowka MJ, Herve P, et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24:861–80.
Joist JH. AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state. Am J Gastroenterol. 1999;94:2801–3.
Frink EJ, Morgan SE, Coetzee A, et al. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology. 1992;76:85–90.
Hunter JM, Parker CJ, Bell CF. The use of different doses of vecuronium in patients with liver dysfunction. Br J Anaesth. 1985;57:758–64.
Magorian T, Wood P, Caldwell J, et al. The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg. 1995;80:754–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Banerjee, G., Piepsney, K., Rajan, S. (2019). Neuroanesthesia and Liver Disease. In: Prabhakar, H., Singhal, V., Gupta, N. (eds) Co-existing Diseases and Neuroanesthesia. Springer, Singapore. https://doi.org/10.1007/978-981-13-2086-6_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-2086-6_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2085-9
Online ISBN: 978-981-13-2086-6
eBook Packages: MedicineMedicine (R0)